Non-invasive, portable and low-cost brain imaging: determining risk for developing dementia in primary care and supporting behaviour change to reduce risk
Award Number
1809_FS_HEAL_DHTC_R3Status / Stage
CompletedDates
1 June 2019 -30 April 2020
Duration (calculated)
00 years 10 monthsFunder(s)
Innovate UK (UKRI)Funding Amount
£48,729.00Funder/Grant study page
Innovate UK UKRIContracted Centre
Mind Over Matter Medtech LtdContracted Centre Webpage
WHO Catergories
Development of clinical assessment of cognition and functionDevelopment of novel therapies
Risk reduction intervention
Disease Type
Dementia (Unspecified)CPEC Review Info
Reference ID | 386 |
---|---|
Researcher | Reside Team |
Published | 12/06/2023 |
Data
Award Number | 1809_FS_HEAL_DHTC_R3 |
---|---|
Status / Stage | Completed |
Start Date | 20190601 |
End Date | 20200430 |
Duration (calculated) | 00 years 10 months |
Funder/Grant study page | Innovate UK UKRI |
Contracted Centre | Mind Over Matter Medtech Ltd |
Contracted Centre Webpage | |
Funding Amount | £48,729.00 |
Abstract
Mind over Matter is developing an end-to-end medical device to identify individuals at high risk of developing dementia whilst their risk remains modifiable, i.e. during mid-life. The accompanying app supports high-risk individuals to reduce their risk by up to half. The low-cost, portable and non-invasive technology combines cutting-edge brain imaging techniques to deliver personalised medicine information in the primary care setting, significantly increasing the specificity of established risk scores based on lifestyle risk factors only, and justifying targeted dementia prevention strategies. In this way, Mind over Matter will dispel the commonly held belief that dementia is a normal part of ageing that can never be prevented, and ignite a dementia prevention movement.